Freenome, Inc. - Common stock (FRNM)

9.9900
-0.0700 (-0.70%)
NASDAQ· Last Trade: Jul 30th, 11:14 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close10.06
Open10.14
Bid10.30
Ask10.65
Day's Range9.980 - 10.43
52 Week Range9.970 - 14.26
Volume582,106
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume751,056

Chart

News & Press Releases

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening –
By Freenome, Inc. · Via GlobeNewswire · July 27, 2026